Barroso-Sousa, Romualdo, et al. “TUMOR MUTATIONAL BURDEN (TMB) IS A POTENTIAL PREDICTOR OF RESPONSE TO IMMUNE CHECKPOINT INHIBITORS (ICI) IN METASTATIC TRIPLE-NEGATIVE BREAST CANCER (MTNBC)”. Mastology, vol. 29, no. 3, Sept. 2019, p. 5, https://revistamastology.emnuvens.com.br/revista/article/view/728.